April 15, 2011

Stockholm, April 15, 2011 — NASDAQ OMX Group Inc. (NASDAQ:NDAQ) announced that Karolinska Development AB (KDEV), a Mid Cap company within the Health Care sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm. Karolinska Development is the first IPO on NASDAQ OMX European markets in 2011.

Karolinska Development's business concept is to create value for investors, patients, and researchers by developing innovations from world-leading research into products that can be sold or licensed with high returns. The company currently has twelve projects in clinical phase, including six in Phase II, with more than 20 compounds deemed to have first in class potential. Read more about Karolinska Development »
 

Follow Karolinska Development´s share information here »
 

NASDAQ OMX welcomes Karolinska Development to the Main Market 
 

 Join the celebration of Karolinska Development´s first day of trading.

View the film from the opening bell here »